This information was published on 2025-10-07T10:21:27 for IP Right Registration Published.
| Field | Value |
| (210) | 2569845 (IR 1865549) |
| (220) |
05 Jun 2025
|
| (300) |
EM, 24 Jan 2025, 019135271
|
| (500) |
The applicant has advised that the word/s appearing in the trade mark may be translated into English as
|
| (511) (510) |
Class 5
Pharmaceutical preparations and substances for the treatment of cardiovascular, metabolic, and renal diseases and disorders. |
| (540) | EXKALBRI |
| (550) | Word |
| (730) |
AstraZeneca AB
|
Find out more about publications on the About page.